Crinetics Pharmaceuticals Inc annual free cash flow for fiscal TTM was -$426 million, a decrease of 10.9% from -$384 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($426M) | ($384M) | ($230M) | ($171M) | ($117M) | ($89M) | ($62M) | ($47M) | ($21M) | ($10M) | ($6M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($95M) | ($126M) | ($93M) | ($112M) | ($89M) | ($90M) | ($66M) | ($61M) | ($49M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CRNX metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All CRNX financial statements → Interactive CRNX charts →
About TickerBase · Data methodology & sources · Privacy · Terms